IL3RA and CD4+/CD56+ hematodermic neoplasm: Differential gene expression analyses revealed alterations in expression of genes (Bcl2, Il3ra that encodes for CD123, Sox4, Igll1, Egfr, Irf4, Cxcr3) that typically dysregulated in BPDCN (Figure 2A).21